Semaglutide and cardiovascular outcomes in patients with overweight or obesity and heart failure: A pre-specified analysis from the SELECT trial
14 May 2024 (08:54 - 09:02)
Organised by: 
Slides
About the speaker
University College London, London (United Kingdom of Great Britain & Northern Ireland)
9 More presentations in this session
Access the full session
The Event
Heart Failure 2024
14 May 2024
08:54 CET
You may be interested in
Congress Session
Congress Presentation
